OncoDaily RT

[OncoDaily RT @OncoDailyRT]

Does Boost Technique Matter in Chemoradiotherapy? – Journal of Contemporary Brachytherapy

@JContBrachyther

https://t.co/6quMgbW94W

[OncoDaily RT @OncoDailyRT]

Freddie Hamdy Receives ASTRO 2026 Honorary Member Award

@DrewMoghanaki @ASTRO_org

https://t.co/6tQ5oIyh0W

[OncoDaily RT @OncoDailyRT]

@DrewMoghanaki We would like to inform you that your post has been published on OncoDaily. Thank you for sharing.
https://t.co/6tQ5oIyh0W

[OncoDaily RT @OncoDailyRT]

@JContBrachyther We would like to inform you that your post has been published on OncoDaily. Thank you for sharing.
https://t.co/6quMgbW94W

[OncoDaily RT @OncoDailyRT]

Advancing Equitable Access to Radiotherapy at the World Cancer Series Europe - Darien Laird

@DarienLaird

https://t.co/511eRoAKyf

[OncoDaily RT @OncoDailyRT]

New in Physics and Imaging in Radiation Oncology

In 58 mediastinal lymphoma patients, IMPT with breath hold achieved the lowest average organ doses compared with VMAT free breathing, VMAT breath hold, and IMPT free breathing.

Mean heart dose
5.4 Gy with IMPT breath hold vs 8.0 Gy with VMAT free breathing
Mean lung dose
6.7 Gy vs 9.2 Gy

Bilateral mean breast dose
2.1 Gy with IMPT vs 3.2 Gy with VMAT
IMPT techniques were optimal for at least 69% of patients, but the best technique varied individually.

For young lymphoma survivors, organ sparing is long-term survivorship care.

https://t.co/Z2DyI5xd2z

[OncoDaily RT @OncoDailyRT]

Do All Patients With Oligometastatic Disease Need SBRT? - David Palma

@drdavidpalma

https://t.co/XYfgJHol3W

[OncoDaily RT @OncoDailyRT]

Can one treatment be enough for localized prostate cancer?

In the prospective multicenter ONE-SHOT trial, single-fraction 19 Gy prostate SBRT achieved a 3-year biochemical relapse-free survival of 92.9% in carefully selected patients with low- or intermediate-risk disease.

At 3 years:
• Grade 2 GU AEs: 9.8%
• Grade 2 GI AEs: 4.9%
• Only one grade 3 event was reported
• GI quality-of-life impact was minimal
The protocol used urethra-sparing planning, real-time motion tracking, and prospective RTQA.
Promising results, but 5-fraction SBRT remains the standard for now. Longer follow-up and larger studies are needed.
https://t.co/7PBKti0cKl

@CiroFranzese

[OncoDaily RT @OncoDailyRT]

Facing Radiotherapy Challenges in Sudan - Moawia Mohammed Ali Elhassan

@moawia_elhassan

https://t.co/MPhYs55qDA

[OncoDaily RT @OncoDailyRT]

Global Collaboration to Strengthen Radiotherapy Programs - Darien Laird

@DarienLaird

https://t.co/j0qwXI1DKW

[OncoDaily RT @OncoDailyRT]

𝗥𝗮𝗱𝗶𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗧𝗵𝗶𝘀 𝗪𝗲𝗲𝗸: 𝗝𝘂𝗻𝗲 𝟭𝟱–𝟮𝟭

From same-day SABR for early-stage lung cancer to more scalable VMAT-TBI verification, this week’s radiotherapy updates show how innovation is reshaping both treatment delivery and patient experience.

📰 New research, major technology milestones, ESTRO recognition, re-irradiation advances, and global efforts to strengthen access to modern radiation therapy are all featured in our latest roundup.

What could faster, safer, and more personalized radiotherapy mean for the future of cancer care?

https://t.co/UlSGdtWgEC

[OncoDaily RT @OncoDailyRT]

☢️ 𝗥𝗲𝗶𝗿𝗿𝗮𝗱𝗶𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗚𝘆𝗻𝗲𝗰𝗼𝗹𝗼𝗴𝗶𝗰 𝗖𝗮𝗻𝗰𝗲𝗿: 𝗧𝗵𝗲 𝗥𝗼𝗹𝗲 𝗼𝗳 𝗕𝗿𝗮𝗰𝗵𝘆𝘁𝗵𝗲𝗿𝗮𝗽𝘆

For carefully selected patients with locoregionally recurrent gynecologic cancer after prior radiation, image-guided brachytherapy may offer a meaningful salvage option delivering focused treatment while trying to protect surrounding organs.

A new systematic review highlights encouraging local-control outcomes, but also a crucial reality: severe late toxicity, inconsistent reporting, and limited quality-of-life data still make every decision highly individualized.

🎯 Precision can create another chance, but only with expert teams, careful selection, and transparent discussion of risk.

Read the full article below:

https://t.co/A5JZ9BXa3w

[OncoDaily RT @OncoDailyRT]

28 Days Until Brachytherapy Awareness Day 2026 - Dr. med. Dr. Hathal Haddad

@Radiooncology

https://t.co/TpG1H2WR5R

[OncoDaily RT @OncoDailyRT]

Jeff White Previews New Workshops and Special Events at ASTRO 2026

@PRJeffWhite

https://t.co/L5inqyvEfp

[OncoDaily RT @OncoDailyRT]

Vivek Ghosh Shares FASTRACK Results Showing 98% Tumor Control at Five Years

@GhoshVivek23

https://t.co/kzx2tyjbbz

[OncoDaily RT @OncoDailyRT]

Nataliya Kovalchuk Highlights VMAT-TBI Experience in the STAT-2 Trial

@NataliyaMedPhys @Applied_RadOnc

https://t.co/csKstdFWT7

[OncoDaily RT @OncoDailyRT]

Dr Katie Wakeham Presents World Radiotherapy Awareness Day to the EmpowerMe Board

@WorldRTDay

https://t.co/lLeXx3l2FM

[OncoDaily RT @OncoDailyRT]

29 Days Until Brachytherapy Awareness Day 2026 - Dr. med. Dr. Hathal Haddad

@Radiooncology

https://t.co/fQUfVhGMiN

[OncoDaily RT @OncoDailyRT]

TDCF Announces PedROC 8.0: Medical Physics Edition in Pediatric Radiation Oncology

@DorcasCancer

https://t.co/9PbiH39tUI